Saponins: The phytochemical with an emerging potential for curing clinical depression

Natural Product Research

Volumn 29, Issue 4, 2015, Pages 302-307

  Abbas, Ghulam ^a   Rauf, Khalid ^a   Mahmood, Wajahat ^a  

^a Department of Pharmacy COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

antidepressant; monoamines; neurogenesis; neuroprotection; neurotrophic factors; saponins

Indexed keywords

CORTICOSTERONE; NEUROTROPHIC FACTOR; SAPONIN DERIVATIVE; ANTIDEPRESSANT AGENT; SAPONIN;

ANTIDEPRESSANT ACTIVITY; APOPTOSIS; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MONOAMINERGIC NERVE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; REVIEW; ANIMAL; CHEMICAL STRUCTURE; DISEASE MODEL; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; RODENT;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOLECULAR STRUCTURE; NEUROGENESIS; PITUITARY-ADRENAL SYSTEM; RODENTIA; SAPONINS; STRESS, PSYCHOLOGICAL;

EID: 84920558126     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2014.942661     Document Type: Review

References (41)

1. aan het Rot M, Mathew SJ, Charney DS. 2009. Neurobiological mechanisms in major depressive disorder. Can Med Assoc J. 180:305-313.
2. Abbas G, Naqvi S, Erum S, Ahmed S, Dar A. 2013. Potential antidepressant activity of Areca catechu Nut via elevation of serotonin and noradrenaline in the hippocampus of rats. Phytother Res. 27:39-45.
3. Berton O, Nestler EJ. 2006. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 7:137-151.
4. Castrén E, Võikar V, Rantamäki T. 2007. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 7:18.
5. Chen L, Dai J, Wang Z, Zhang H, Huang Y, Zhao Y. 2014. Ginseng total saponins reverse corticosterone-induced changes in depression-like behavior and hippocampal plasticity-related proteins by interfering with GSK-3β-CREB signaling pathway. Evid Based Complement Alternat Med. 2014:506735.
6. Chin Y-W, Balunas MJ, Chai HB, Kinghorn AD. 2006. Drug discovery from natural sources. AAPS J. 8:E239-E253.
7. Cui J, Jiang L, Xiang H. 2012. Ginsenoside Rb3 exerts antidepressant-like effects in several animal models. J Psychopharmacol. 26:697-713.
8. Dang H, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y. 2009. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 33:1417-1424.
9. David DJ, Samuels BA, Rainer Q, Wang J-W, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux J-P. 2009. Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression. Neuron. 62:479-493.
10. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn A-M, Nordborg C, Peterson DA, Gage FH. 1998. Neurogenesis in the adult human hippocampus. Nat Med. 4:1313-1317.
11. Frost P, Bornstein S, Ehrhart-Bornstein M, O'Kirwan F, Hutson C, Heber D, Go V, Licinio J, Wong M-L. 2003. The prototypic antidepressant drug, imipramine, but not Hypericum perforatum (St. John's Wort), reduces HPAaxis function in the rat. Horm Metab Res. 35:602-606.
12. Galeotti N, Bartolini A, Ghelardini C. 2006. Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. Neuropharmacology. 50:309-316.
13. Gartside S, Cowen P. 2006. Pharmacology of drugs used in the treatment of mood disorders. Psychiatry. 5:162-166.
14. Jiang B, Xiong Z, Yang J, Wang W, Wang Y, Hu ZL, Wang F, Chen JG. 2012. Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol. 166:1872-1887.
15. Jin Z-L, Gao N, Zhang J-R, Li X-R, Chen H-X, Xiong J, Li Y-F, Tang Y. 2014. The discovery of Yuanzhi-1, a triterpenoid saponin derived from the traditional Chinese medicine, has antidepressant-like activity. Prog Neuro-Psychopharmacol Biol Psychiatry. 53:9-14.
16. Khan A, Musgnung J, Ramey T, Messig M, Buckley G, Ninan PT. 2014. Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d. J Clin Psychopharmacol. 34:365-368.
17. Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S. 2011. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuro-Psychopharmacol Biol Psychiatry. 35:1284-1290.
18. Li L-F, Lu J, Li X-M, Xu C-L, Yang J, Qu R, Ma S-P. 2012. Antidepressant-like effects of the saponins extracted from Chaihu-jia-longgu-muli-tang in a rat unpredictable chronic mild stress model. Fitoterapia. 83:93-103.
19. Li S-X, Mu Y, Zheng F-Y. 2013. Influence of gastrointestinal digestion and edible plant combination on oral bioavailability of triterpene saponins, using a biomimetic digestion and absorption system and determination by HPLC. J Agric Food Chem. 61:10599-10603.
20. Liu X, Liu F, Yue R, Li Y, Zhang J, Wang S, Zhang S, Wang R, Shan L, Zhang W. 2013. The antidepressant-like effect of bacopaside I: possible involvement of the oxidative stress system and the noradrenergic system. Pharmacol Biochem Behav. 110:224-230.
21. Liu Y, Ma S, Qu R. 2010. SCLM, total saponins extracted from Chaihu-jia-longgu-muli-tang, reduces chronic mild stress-induced apoptosis in the hippocampus in mice. Pharm Biol. 48:840-848.
22. Mathers C, Fat DM, Boerma J. 2008. The global burden of disease: 2004 update. Geneva: World Health Organization.
23. Rauf K, Subhan F, Abbas M, Ali SM, Ali G, Ashfaq M, Abbas G. 2013. Inhibitory effect of bacopasides on spontaneous morphine withdrawal induced depression in mice. Phytother Res.
24. Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J. 2011. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res. 221:166-171.
25. Rishikesh B, Kumar RS, Perumal P. 2012. Anxiolytic and antidepressant activity of saponin fraction of Trichopus zeylanicus Gaertn in mice. Int J Phytopharmacol 3, p. 269-274.
26. Rojas P, Serrano-García N, Medina-Campos ON, Pedraza-Chaverri J, Ögren SO, Rojas C. 2011. Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: role of oxidative stress. Neurochem Int. 59:628-636.
27. Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, Rahman Z, Ring RH, Schechter LE. 2007. Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther. 113:134-153.
28. Russo-Neustadt A, Beard RC, Cotman CW. 1999. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology. 21:679-682.
29. Schmidt HD, Banasr M, Duman RS. 2008. Future antidepressant targets: neurotrophic factors and related signaling cascades. Drug Discov Today Ther Strateg. 5:151-156.
30. Singh GK, Garabadu D, Muruganandam A, Joshi VK, Krishnamurthy S. 2009. Antidepressant activity of Asparagus racemosus in rodent models. Pharmacol Biochem Behav. 91:283-290.
31. Sparg S, Light M, Van Staden J. 2004. Biological activities and distribution of plant saponins. J Ethnopharmacol. 94:219-243.
32. Sun X, Shi Z, Li T, Pan R, Liu X, Bu L, Kong L, Chang Q. 2012. Antidepressant-like effects of total saikosaponins of Bupleurum yinchowense in mice. J Ethnopharmacol 148, p. 794-803.
33. Taupin P. 2008. Neurogenic factors are targets in depression. Drug Discov Today Ther Strateg. 5:157-160.
34. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. 2003. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos. 31:1065-1071.
35. Xiang H, Liu Y, Zhang B, Huang J, Li Y, Yang B, Huang Z, Xiang F, Zhang H. 2011. The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of Panax notoginseng in animal models of depression. Phytomedicine. 18:731-738.
36. Xiong J, Guo J, Huang L, Meng B, Ping Q. 2008. The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats. Drug Dev Ind Pharm. 34:65-72.
37. Xu C, Teng J, Chen W, Ge Q, Yang Z, Yu C, Yang Z, Jia W. 2010. 20 (S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests. Prog Neuro-Psychopharmacol Biol Psychiatry. 34:1402-1411.
38. Yu K, Chen F, Li C. 2012. Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more? Curr Drug Metab. 13:577-598.
39. Zhang D, Wen X-S, Wang X-Y, Shi M, Zhao Y. 2009. Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress. J Ethnopharmacol. 123:55-60.
40. Zhou Y, Shen Y-H, Zhang C, Su J, Liu R-H, Zhang W-D. 2007. Triterpene saponins from Bacopa monnieri and their antidepressant effects in two mice models. J Nat Prod. 70:652-655.
41. Zhu W, Ma S, Qu R, Kang D. 2006. Antidepressant-like effect of saponins extracted from Chaihu-jia-longgu-muli-tang and its possible mechanism. Life Sci. 79:749-756.